Skip to main content
Figure 1 | Arthritis Research & Therapy

Figure 1

From: The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study

Figure 1

A proposed screening model for systemic sclerosis-related pulmonary arterial hypertension (SSc-PAH). 6MWT, six-minute walk test; DLCO, diffusion capacity of lungs to carbon monoxide (% predicted); FVC, forced vital capacity (% predicted); HRCT, high-resolution computed tomography (of lung); NT-proBNP, N-terminal pro-brain natriuretic peptide (pg/ml); PFT, pulmonary function test.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us